Resources
Antib Ther, Vol. 7, Issue 3, Pages 256-265, 2024
PMID: 39262441
Recombinant antibodies (rAbs) have emerged as a promising solution to tackle antigen specificity, enhancement of immunogenic potential and versatile functionalization to treat human diseases. The development of single chain variable fragments has helped accelerate treatment in cancers and viral infections, due to their favorable pharmacokinetics and human compatibility.
Company
Resources
Research
Diagnostics
Contact